Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses

被引：1
作者：
Li, Zijun [1 ,2 ]
Lee, Joo-Eun [2 ]
Cho, Namki [2 ]
Yoo, Hee Min [1 ,3 ]
机构：
[1] Korea Res Inst Stand & Sci KRISS, Biometrol Grp, Daejeon 34113, South Korea
[2] Chonnam Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Gwangju 61186, South Korea
[3] Univ Sci & Technol UST, Dept Precis Measurement, Daejeon 34113, South Korea
来源：
HELIYON | 2023年 / 9卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
Natural products; SARS-CoV-2; Pseudotyped viruses; Antiviral activity; Reactive oxygen species; USNIC ACID; HOSPITALIZED-PATIENTS; USNEA-BARBATA; IN-VITRO; TOCILIZUMAB; ANTIFUNGAL; EXTRACTS;
D O I：
10.1016/j.heliyon.2023.e21742
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The escalating pandemic brought about by the novel SARS-CoV-2 virus is threatening global health, and thus, it is necessary to develop effective antiviral drugs. Usenamine A is a dibenzofuran derivative separated from lichen Usnea diffracta showing broad-spectrum activity against different viruses. We evaluate that usenamine A has antiviral effects against novel SARS-CoV-2 Delta variant pseudotyped viruses (PVs) in A549 cells. In addition, usenamine A significantly suppresses SARS-CoV-2 PV-induced mitochondrial depolarization, elevated reactive oxygen species (ROS) levels, apoptosis, and inflammation. Usenamine A also causes the SARS-CoV-2 spike protein to become less stable. Thus, usenamine A shows potential as an antiviral drug that can provide protection against COVID-19.
引用
收藏
页数：14
相关论文
共 50 条
  • [31] New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
    Gentile, Davide
    Fuochi, Virginia
    Rescifina, Antonio
    Furneri, Pio Maria
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 16
  • [32] Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
    Meng, Jie-Ru
    Liu, Jiazheng
    Fu, Lu
    Shu, Tong
    Yang, Lingzhi
    Zhang, Xueji
    Jiang, Zhi-Hong
    Bai, Li-Ping
    [J]. VIRUSES-BASEL, 2023, 15 (01):
  • [33] Prevalence and consequential outcomes of concurrent infections involving both SARS-CoV-2 and influenza viruses
    Mahmood, Asif
    Shama, Shahid
    Mehmood, Shahid
    Ullah, Kaleem
    Ullah, Niamat
    Zhang, Wen
    [J]. KUWAIT MEDICAL JOURNAL, 2024, 56 (04):
  • [34] The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2
    Engin, Ayse Basak
    Engin, Evren Doruk
    Engin, Atilla
    [J]. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2021, 81
  • [35] Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
    Tran Thi Nhu Thao
    Labroussaa, Fabien
    Ebert, Nadine
    V'kovski, Philip
    Stalder, Hanspeter
    Portmann, Jasmine
    Kelly, Jenna
    Steiner, Silvio
    Holwerda, Melle
    Kratzel, Annika
    Gultom, Mitra
    Schmied, Kimberly
    Laloli, Laura
    Huesser, Linda
    Wider, Manon
    Pfaender, Stephanie
    Hirt, Dagny
    Cippa, Valentina
    Crespo-Pomar, Silvia
    Schroeder, Simon
    Muth, Doreen
    Niemeyer, Daniela
    Corman, Victor M.
    Mueller, Marcel A.
    Drosten, Christian
    Dijkman, Ronald
    Jores, Joerg
    Thiel, Volker
    [J]. NATURE, 2020, 582 (7813) : 561 - +
  • [36] Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
    Xiao, Ting
    Cui, Mengqi
    Zheng, Caijuan
    Wang, Ming
    Sun, Ronghao
    Gao, Dandi
    Bao, Jiali
    Ren, Shanfa
    Yang, Bo
    Lin, Jianping
    Li, Xiaoping
    Li, Dongmei
    Yang, Cheng
    Zhou, Honggang
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts
    Shadrack, Daniel M.
    Vuai, Said A. H.
    Sahini, Mtabazi G.
    Onoka, Isaac
    [J]. RSC ADVANCES, 2021, 11 (43) : 26524 - 26533
  • [38] Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: From in silico to in vitro Validation
    Alexpandi, Rajaiah
    Gendrot, Mathieu
    Abirami, Gurusamy
    Delandre, Oceane
    Fonta, Isabelle
    Mosnier, Joel
    Mariadasse, Richard
    Jeyakanthan, Jeyaraman
    Pandian, Shunmugiah Karutha
    Pradines, Bruno
    Ravi, Arumugam Veera
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [39] Aptamer-based Emerging Tools for Viral Biomarker Detection: A Focus on SARS-CoV-2
    Kulabhusan, Prabir Kumar
    Pishva, Parsa
    capkin, Eda
    Tambe, Prajakta
    Yuece, Meral
    [J]. CURRENT MEDICINAL CHEMISTRY, 2023, 30 (08) : 910 - 934
  • [40] The anti SARS-CoV-2 activity of nanofibrous filter materials activated with metal clusters
    Thomberg, T.
    Bulgarin, H.
    Lust, A.
    Nerut, J.
    Koppel, M.
    Romann, T.
    Palm, R.
    Mansson, M.
    March, N. M. Flores
    Junninen, H.
    Kulaviir, M.
    Paiste, P.
    Kirsimae, K.
    Punapart, M.
    Viru, L.
    Merits, A.
    Lust, E.
    [J]. ATMOSPHERIC ENVIRONMENT-X, 2023, 17
12345